Alerje Inc., a Detroit-based food allergy management company, has announced a smartphone case that houses an auto-injector, allowing quick access to Epinephrine during severe allergic reactions.
The International Data Corp. (IDC Research) states that 79 percent of adults have their smartphones with them 22 hours a day. The Omniject attaches to a smartphone, and aside from quick access, it will automatically alert the patients support circle through the Alerje smartphone app if a dose is discharged from the case.
According to the CDC’s Voluntary Guidelines for Schools, delay or failure to deliver Epinephrine can contribute to fatal cases of food-related anaphylaxis. Food allergies affect over 220 million people worldwide, and according to the CDC, emergency room visits for food allergy emergencies have increased 214 percent in the last two years.
Along with the support system alert, the Alerje app has a food tracking feature which allows users to track which foods could be dangerous to them and adhere better to their dietary restrictions.
Alerje is committed to increasing the quality of life for millions dealing with life-threatening food allergies. Its technology simplifies food allergy management, reducing the stress for caregivers as they strive to prevent potentially deadly anaphylaxis incidents.
The app is available to download from the Google Play and Apple App stores. The release date for the Omniject case has not been announced.